Cargando…
Evaluation of Conjunctival Autografting Augmented with Mitomycin C Application versus Ologen Implantation in the Surgical Treatment of Recurrent Pterygium
OBJECTIVES: To evaluate the safety and efficacy of augmenting conjunctival autografting with intraoperative mitomycin C (MMC) application versus Ologen implantation in the management of recurrent pterygium. MATERIALS AND METHODS: This prospective randomised study included 63 eyes of 63 patients, wit...
Autores principales: | Wagdy, Faried M., Farahat, Hassan G., Ellakwa, Amin F., Mandour, Sameh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815381/ https://www.ncbi.nlm.nih.gov/pubmed/33505715 http://dx.doi.org/10.1155/2021/8820926 |
Ejemplares similares
-
Ologen Implantation versus Conjunctival Autograft Transplantation for Treatment of Pterygium
por: Chen, Xiuping, et al.
Publicado: (2018) -
Biodegradable collagen matrix (Ologen™) implant and conjunctival autograft for scleral necrosis after pterygium excision: two case reports
por: Cho, Chan-Ho, et al.
Publicado: (2015) -
The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium
por: Fakhry, Mohamed A
Publicado: (2011) -
Recurrence rate with use of intraoperative Mitomycin C versus Conjunctival Autograft following pterygium excision
por: Paracha, Quratulain, et al.
Publicado: (2014) -
Surgical outcome of conjunctival rotational autograft-mitomycin C (MMC) versus free conjunctival autograft-MMC for pterygium removal: A randomized clinical trial
por: Bamdad, Shahram, et al.
Publicado: (2017)